Linden Thomas Advisory Services’s Idexx Laboratories IDXX Stock Holding History

Linden Thomas Advisory Services’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.14M	Sell	7,872 -128	-2%	-$71.8K	0.33%	72
2026 Q1	$4.5M	Buy	8,000 +144	+2%	+$92.3K	0.43%	54
2025 Q4	$5.31M	Buy	7,856 +31	+0.4%	+$21.1K	0.54%	33
2025 Q3	$5M	Buy	7,825 +28	+0.4%	+$17K	0.51%	39
2025 Q2	$4.18M	Buy	7,797 +66	+0.9%	+$31.6K	0.46%	48
2025 Q1	$3.25M	Buy	7,731 +295	+4%	+$128K	0.42%	51
2024 Q4	$3.07M	Buy	7,436 +169	+2%	+$74.1K	0.39%	59
2024 Q3	$3.67M	Buy	7,267 +158	+2%	+$76.8K	0.5%	31
2024 Q2	$3.46M	Buy	7,109 +931	+15%	+$467K	0.54%	26
2024 Q1	$3.34M	Buy	6,178 +233	+4%	+$127K	0.54%	24
2023 Q4	$3.3M	Buy	5,945 +328	+6%	+$154K	0.62%	14
2023 Q3	$2.46M	Buy	5,617 +771	+16%	+$384K	0.55%	19
2023 Q2	$2.43M	Buy	4,846 +144	+3%	+$69K	0.54%	30
2023 Q1	$2.35M	Buy	4,702 +115	+3%	+$55K	0.58%	28
2022 Q4	$1.87M	Buy	+4,587	New	+$1.78M	0.53%	39

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Linden Thomas Advisory Services's IDXX Position: Q2 2026 in Review

Linden Thomas Advisory Services reduced its Idexx Laboratories (IDXX) stake by 1.6% in Q2 2026, selling an estimated $71.8K and leaving 7,872 shares worth $4.14M. The position accounts for 0.33% of the portfolio, ranked #72.

Linden Thomas Advisory Services first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.31M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Linden Thomas Advisory Services held 7,872 shares of Idexx Laboratories worth $4.14M as of Q2 2026.
Linden Thomas Advisory Services sold 128 Idexx Laboratories shares in Q2 2026, an estimated $71.8K.
Idexx Laboratories made up 0.33% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #72 holding.
Linden Thomas Advisory Services first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
Linden Thomas Advisory Services's Idexx Laboratories position peaked at $5.31M in Q4 2025.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.